XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Restricted Stock Unit and Award Activity

A summary of RSU activity during the periods indicated is as follows:

 

 

 

Number of Restricted Stock Units

 

 

Weighted Average Grant-Date Fair Value per Share

 

Balance at December 31, 2021

 

 

596,500

 

 

$

19.56

 

Granted

 

 

443,400

 

 

$

13.21

 

Forfeited

 

 

(43,400

)

 

$

19.56

 

Balance at March 31, 2022

 

 

996,500

 

 

$

16.73

 

 

A summary of RSA activity during the periods indicated is as follows:

 

 

 

Number of Restricted Stock Awards

 

 

Weighted Average Grant-Date Fair Value per Share

 

Balance at December 31, 2021

 

 

113,173

 

 

$

6.15

 

Vested

 

 

(16,810

)

 

$

6.17

 

Balance at March 31, 2022

 

 

96,363

 

 

$

6.15

 

Summary of Components of Equity-based Compensation Expense

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Research and development

 

$

1,246

 

 

$

226

 

General and administrative

 

 

1,659

 

 

 

226

 

Total equity-based compensation

 

$

2,905

 

 

$

452

 

Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Options and Options for Common Units Activity A summary of stock option activity during the periods indicated is as follows:

 

 

 

Number of Stock Option Awards

 

 

Weighted Average Exercise Price

 

 

Weighted
Average
Remaining Contractual Term (in years)

 

 

Aggregate Intrinsic Value (in thousands)

 

Balance at December 31, 2021

 

 

2,300,819

 

 

$

14.12

 

 

 

9.55

 

 

$

976

 

Granted

 

 

1,081,437

 

 

$

13.38

 

 

 

9.96

 

 

$

299

 

Forfeited

 

 

(6,500

)

 

$

26.78

 

 

 

 

 

 

 

Balance at March 31, 2022

 

 

3,375,756

 

 

$

13.86

 

 

 

9.53

 

 

$

5,677

 

Exercisable at March 31, 2022

 

 

133,775

 

 

$

9.44

 

 

 

9.21

 

 

$

543

 

Nonvested at March 31, 2022

 

 

3,241,981

 

 

$

14.04

 

 

 

9.54

 

 

$

5,134